What do you think they are doing with these open At-The-Money Offerings???
All of the clinical information can be found on the website. There is an August 2014 corporate presentation link on their landing page. By year end, I believe Synta will have new messaging and branding to support ganetespib by virtue of them retaining the Navicor Group in April.
My guess is the Company will have somewhere around $120 million on the balance sheet by the time we get to the next quarterly call (in November), providing them a runway into 1H2016 (which can obviously be extended should they sign a distribution deal taking a chunk of the cash upfront).
Oh, and yes, don't be lazy. It's your money...get on it.